Why are patients still getting and dying from acute kidney injury?

Current Opinion in Critical Care

Volumn 22, Issue 6, 2016, Pages 513-519

  Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Classification; Epidemiology; Treatment

Indexed keywords

ACUTE KIDNEY FAILURE; DISEASE COURSE; DYING; GLOMERULUS FILTRATION; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; REVIEW; SEPSIS; COMPLICATION; KIDNEY; MORTALITY; PATHOLOGY;

ACUTE KIDNEY INJURY; HUMANS; KIDNEY; SEPSIS;

EID: 84992143149     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000358     Document Type: Review

References (56)

1. Al-Khafaji A, Nadim MK, Kellum JA. Hepatorenal disorders. Chest 2015; 148:550-558.
2. Vandenberghe W, Gevaert S, Kellum JA, et al. Acute kidney injury in cardiorenal syndrome type 1 patients: a systematic review and meta-analysis. Cardiorenal Med 2016; 6:116-128.
3. Kane-Gill SL, LeBlanc JM, Dasta JF, et al. A multicenter study of the point prevalence of drug-induced hypotension in the ICU. Crit Care Med 2014; 42:2197-2203.
4. Gomez H, Ince C, De Backer D, et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014; 41:3-11.
5. Diamandopoulos A. Twelve centuries of nephrological writings in the Graeco-Roman world of the Eastern Mediterranean (from Hippocrates to Aetius Amidanus). Nephrol Dial Transplant 1999; 14 (Suppl 2):2-9.
6. KDIGO AKI Workgroup. Kidney Disease: Improving Global Outcomes (KDI-GO) clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2:1-138.
7. Kellum JA. Acute kidney injury. Crit Care Med 2008; 36:S141-S145.
8. Kellum JA. Diagnostic criteria for acute kidney injury: present and future. Crit Care Clin 2015; 31:621-632.
9. Kellum JA, Bellomo R, Ronco C. Does this patient have acute kidney injury? An AKI checklist. Intensive Care Med 2016; 42:96-99.
10. Haase M, Kellum JA, Ronco C. Subclinical AKI-an emerging syndrome with important consequences. Nat Rev Nephrol 2012; 8:735-739.
11. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380:756-766.
12. Fuhrman DY, Kellum JA. Biomarkers for diagnosis, prognosis and intervention in acute kidney injury. Contrib Nephrol 2016; 187:47-54.
13. Liu KD, Vijayan A, Rosner MH, et al. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2∗IGFBP7 biomarker study. Nephrol Dial Transplant 2016. [Epub ahead of print]
14. Kellum JA, Bellomo R, Ronco C. Kidney attack. JAMA 2012; 307:2265-2266.
15. Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007; 18:1292-1298.
16. Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015; 41:1411-1423.
17. Kellum JA, Sileanu FE, Murugan R, et al. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 2015; 26:2231-2238.
18. Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nat Rev Nephrol 2011; 7:209-217.
19. Amin AP, Salisbury AC, McCullough PA, et al. Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med 2012; 172:246-253.
20. Goldstein SL, Kirkendall E, Nguyen H, et al. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 2013; 132:e756-e767.
21. Goldstein SL. Medication-induced acute kidney injury. Curr Opin Crit Care 2016.
22. Garg AX, Devereaux PJ, Yusuf S, et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA 2014; 311:2191-2198.
23. Zarbock A, Schmidt C, Van Aken H, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 2015; 313:2133-2141.
24. Hausenloy DJ, Candilio L, Evans R, et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 2015; 373:1408-1417.
25. Meybohm P, Bein B, Brosteanu O, et al. A multicentertrial of remote ischemic preconditioning for heart surgery. N Engl J Med 2015; 373:1397-1407.
26. Meersch M, Zarbock A. Renal protection in the 21st century. Curr Opin Crit Care 2016.
27. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-134.
28. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911.
29. Sileanu FE, Murugan R, Lucko N, et al. AKI in low-risk versus high-risk patients in intensive care. Clin J Am Soc Nephrol 2015; 10:187-196.
30. Kane-Gill SL, Sileanu FE, Murugan R, et al. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis 2015; 65:860-869.
31. Dasta JF, Kane-Gill SL, Durtschi AJ, et al. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008; 23:1970-1974.
32. Srisawat N, Sileanu FE, Murugan R, et al. Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study. Am J Nephrol 2015; 41:81-88.
33. Wilson FP, Shashaty M, Testani J, et al. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet 2015; 385:1966-1974.
34. Kellum JA, Kane-Gill SL, Handler SM. Can decision support systems work for acute kidney injury? Nephrol Dial Transplant 2015; 30:1786-1789.
35. Kashani K. Computer decision support for acute kidney injury; current and future. Curr Opin Crit Care 2016.
36. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery. Ann Surg 2012; 255:821-829.
37. Watkins SC, Shaw AD. Fluid resuscitation for acute kidney injury-an empty promise. Curr Opin Crit Care 2016.
38. Kellum JA, Chawla LS, Keener C, et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med 2016; 193:281-287.
39. DeAlmeida D, Al-Jaghbeer M, Abdelhak M, Kellum JA. A study to evaluate the effectiveness of the currently utilized acute kidney injury (AKI) alert: a use case example for a learning health system. In: 48th Hawaii International Conference on System Sciences (HICSS); 2015. p. 3125-3131.
40. Palant CE, Chawla LS, Faselis C, et al. High serum creatinine nonlinearity: a renal vital sign? Am J Physiol Renal Physiol 2016; 311:F305-F309.
41. Murray PT, Mehta RL, Shaw A, et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int 2014; 85:513-521.
42. Kellum JA, Chawla LS. Cell-cycle arrest and acute kidney injury: the light and the dark sides. Nephrol Dial Transplant 2015; 31:16-22.
43. FDA allows marketing of the first test to assess risk of developing acute kidney injury. FDA. http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce-ments/ucm412910.htm [Accessed 5 September 2016].
44. Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17:R25.
45. Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014; 189:932-939.
46. Heung M, Ortega LM, Chawla LS, et al. Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury. Nephrol Dial Transplant 2016. [Epub ahead of print]
47. Honore PM, Nguyen HB, Gong M, et al. Urinary tissue inhibitor of metallo-proteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med 2016. [Epub ahead of print]
48. Gunnerson KJ, Shaw AD, Chawla LS, et al. TIMP2IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. J Trauma Acute Care Surg 2016; 80:243-249.
49. Koyner JL, Shaw AD, Chawla LS, et al. Tissue inhibitor metalloproteinase-2 (TIMP-2)-IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 2015; 26:1747-1754.
50. Peng Z-Y, Zhou F, Kellum JA. Cross-species validation of cell cycle arrest markers for acute kidney injury in the rat during sepsis. Intensive Care Med Exp 2016; 4:12.
51. Kellum JA, Devarajan P. What can we expect from biomarkers for acute kidney injury? Biomark Med 2014; 8:1239-1245.
52. Huen SC, Parikh CR. Molecular phenotyping of clinical AKI with novel urinary biomarkers. Am J Physiol Renal Physiol 2015; 309:F406-F413.
53. Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 2016; 315:2190-2199.
54. Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016; 375:122-133.
55. Kellum JA, Murugan R. Effects of non-severe acute kidney injury on clinical outcomes in critically ill patients. Crit Care 2016; 20:159.
56. Kellum JA, Ronco C, Bellomo R. Acute kidney disease and the community. Lancet 2016; 387:1974-1976.